Alpha Teknova, Inc. cotiza a 8.22 USD y tiene una capitalización bursátil de $441M. En los últimos 12 meses ha facturado $44M con un margen de flujo de caja libre del -24.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.05 | $-0.08 | $-0.09 |
| Estimado | $-0.05 | $-0.07 | $-0.09 | $-0.09 |
| Sorpresa | — | +28.6% | +11.1% | +0.0% |
| Métrica | TKNO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 33.2% | 57.0% | -23.9% |
| Operating Margin | -41.9% | -38.6% | -3.3% |
| Net Margin | -42.6% | -33.6% | -9.0% |
| FCF Margin | -24.2% | -13.9% | -10.3% |
| ROE | -25.1% | -40.4% | +15.3% |
| ROA | -16.7% | -32.0% | +15.3% |
| Current Ratio | 4.58 | 2.84 | +1.74 |
| Debt / Equity | 0.19 | 0.28 | -0.09 |